Neonatal-Onset Multisystem Inflammatory Disease (NOMID)

DBCOND0094035Congenital, Hereditary, and Neonatal Diseases and Abnormalitiesimmediate and delayed hypersensitivity reactions

Neonatal-Onset Multisystem Inflammatory Disease (NOMID) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
neonatal-onset multisystem inflammatory disease · Neonatal Onset Multisystem Inflammatory Disease · NOMID · CINCA Syndrome · Neonatal-onset multisystemic inflammatory disease
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT732368ICD-10M04.2SNOMED CT239826001MedDRA10064568UMLSC0409818

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Neonatal-Onset Multisystem Inflammatory Disease (NOMID) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In